Dementia-Like Behavior Discovered in Pre-Cancerous Cells
Researchers have uncovered a startling link between the mechanisms of dementia and the origins of pancreatic cancer, stemming…
Doctors’ skills get worse once they’ve used AI, warns Lancet study
As healthcare becomes smarter, will doctors become dumber? The rise of AI assistants that write consultation notes or…
Neoadjuvant Immunotherapy Shows Promise in Limited-Stage SCLC
Small cell lung cancer: © Констянтин Батыльчук- stock.adobe.com Neoadjuvant immunotherapy combined with chemotherapy has demonstrated promising efficacy and…
Study Reveals Missed Opportunities for Surgical Prevention of Ovarian Cancer
Illustration of ovarian cancer: © blueringmedia – stock.adobe.com One-fourth of patients with high-grade serous carcinoma (HGSC) may have…
Pembrolizumab Hits Nearly 90% Response Rate in Desmoplastic Melanoma
Melanoma: © David A Litman – stock.adobe.com Pembrolizumab (Keytruda) elicited a clinical response in nearly 90% of patients…
Colorectal cancer rates nearly triple among younger people in Sweden
According to a study by Karolinska Institutet, nearly three times as many people under the age of 50…
New drug-releasing system eliminates tumors in 82% of high-risk bladder cancer patients
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for…
Metastatic Bone Cancer Immune Suppression Linked to Neutrophils, DKK1
Credit: Paul Biris/Getty Images Bone metastases in cancer patients resist immune checkpoint blockade (ICB) therapies by hijacking key…
Genetic testing can guide safer chemotherapy for gastrointestinal cancer patients
For some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes life-threatening…
Early-onset pancreatic cancer patients benefit more from neoadjuvant chemotherapy and surgery
Background and objectives The incidence of early-onset pancreatic cancer (EOPC) is rising, yet optimal treatment strategies remain unclear.…
Many patients with high-risk myelodysplastic syndromes do not receive guideline-recommended treatment
Most patients with high-risk myelodysplastic syndromes (MDS) do not receive guideline-recommended treatment with hypomethylating agents (HMAs), according to…
Clinical insights from lymphoid structures
Sponsored Content by TissueGnosticsReviewed by Maria OsipovaJul 31 2025 In this interview, we spoke with Associate Professor Diana…